Overview

Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents

Status:
Recruiting

Trial end date:
2022-06-18

Target enrollment:

Participant gender:

Summary

Severely brain injured patients are at high risk of intracranial hypertension. Among medical treatments (sedatives), neuromuscular blocking agents (NMBA) are recommended by french but not english speaking societies. Effects of NMBA are unknown. The present study is designed to compare the effects of NMBA versus placebo in the treatment of intracranial hypertension, and the underlying physiopathologic effects.

Phase:

Phase 4

Details

Lead Sponsor:

University Hospital, Clermont-Ferrand

Treatments:

Atracurium
Cisatracurium
Neuromuscular Blocking Agents